MarketPeel
Insider Trading Intelligence
ML

Mollie Leoni

KURA
CHIEF MEDICAL OFFICER · KURA ONCOLOGY, INC. · CIK 0002051106
FILING MIX · LIFETIME35%/65%
BUYS
6
SELLS
11
TOTAL VALUE
$1.23M
COMPANIES
1
ACTIVE SINCE
Jan 2025
HOLDINGS NOW
182,345
AVG SELL PX
$9.74
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
10 backtested trades · 8 horizons · 20 pending
Forward-return performance of every backtestable P/S trade by Mollie Leoni, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d10+50.00%+5.53%-0.60%+6.12%+4.83%
14d10+40.00%+1.86%+0.02%+1.84%+6.92%
30d10+50.00%+1.09%-1.16%+2.25%+2.35%
60d10+90.00%-5.40%-6.03%+0.63%-0.63%
90d10+50.00%-4.84%-1.81%-3.04%-1.68%
180d10(4 pending)+100.00%-18.36%+4.79%-23.15%-25.95%
1y10(6 pending)+0.00%+3.48%+15.38%-11.91%-11.91%
2y10(10 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KURA · 182,345 shares · as of Jun 18, 2026
068,864137,727206,591275,4542026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2025
2026
2026
FLOW · 6 buys / 11 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KURA
KURA ONCOLOGY, INC.
SALE10b5-1
10b5-1 plan
84,929$9.82$834.3K182,345Jun 18, 2026Jun 22, 2026View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Medical Officer
3,655$8.46$30.9K271,799Jan 27, 2026Jan 27, 2026View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Medical Officer
2,233$8.46$18.9K269,566Jan 27, 2026Jan 27, 2026View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Medical Officer
1,341$8.46$11.3K267,274Jan 27, 2026Jan 27, 2026View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Medical Officer
951$8.46$8.0K268,615Jan 27, 2026Jan 27, 2026View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
50,000275,454Jan 2, 2026Jan 6, 2026View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
100,000100,000Jan 2, 2026Jan 6, 2026View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Medical Officer
15,485$11.18$173.1K225,454Nov 14, 2025Nov 14, 2025View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
82,500240,939Nov 13, 2025Nov 14, 2025View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Medical Officer
12,314$8.94$110.1K158,439Sep 29, 2025Sep 29, 2025View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
82,500170,753Sep 27, 2025Sep 29, 2025View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Medical Officer
1,353$7.87$10.7K89,610Jan 28, 2025Jan 28, 2025View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Medical Officer
541$7.87$4.3K88,253Jan 28, 2025Jan 28, 2025View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Medical Officer
816$7.87$6.4K88,794Jan 28, 2025Jan 28, 2025View →
KURA
KURA ONCOLOGY, INC.
SALE
Chief Medical Officer
2,253$7.87$17.7K90,963Jan 28, 2025Jan 28, 2025View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
46,25093,216Jan 2, 2025Jan 7, 2025View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
92,50092,500Jan 2, 2025Jan 7, 2025View →
Other insiders · KURA
Loading peer insiders…
About this filer
CIK 0002051106
ROLE
Chief Medical Officer
PRIMARY
KURA
COMPANIES
1
ACTIVE SINCE
Jan 2025
MARKETPEEL · /INSIDER/0002051106DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback